Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Neuzil

Showing results (231-240 of 263) with videos related to

Pageof 27
Sort By:
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2010
PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO studyYves-Laurent Bayard, Heyder Omran, Petr Neuzil, et al.
Heart Rhythm|February 8, 2026
Impact of linear ablation in persistent atrial fibrillation using a dual energy, wide-footprint catheter - Analysis from the SPHERE Per-AF Randomized TrialMoussa Mansour, Dinesh Sharma, Erich L Kiehl, et al.
Heart Rhythm O2|April 27, 2026
Same day discharge can be performed safely after atrial fibrillation catheter ablation using a wide-footprint lattice-tip dual-energy systemTyler L Taigen, Devi G Nair, Dinesh Sharma, et al.
Journal of the American College of Cardiology|November 8, 2021
4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial FibrillationPavel Osmancik, Dalibor Herman, Petr Neuzil, et al.
Journal of Cardiovascular Electrophysiology|August 2, 2023
Nonprocedural bleeding after left atrial appendage closure versus direct oral anticoagulants: A subanalysis of the randomized PRAGUE-17 trialMarian Branny, Pavel Osmancik, Petr Kala, et al.
Journal of the American College of Cardiology|June 27, 2020
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial FibrillationPavel Osmancik, Dalibor Herman, Petr Neuzil, et al.
European Journal of Heart Failure|March 17, 2026
Long-term Safety and Performance of an Implantable IVC Sensor for Congestion-Guided Management in Heart Failure: 12-Month Results from the FUTURE-HF Trial PortfolioKevin Damman, Nir Uriel, Mandeep R Mehra, et al.
The New England Journal of Medicine|November 10, 2015
A Leadless Intracardiac Transcatheter Pacing SystemDwight Reynolds, Gabor Z Duray, Razali Omar, et al.
European Journal of Heart Failure|July 15, 2025
Cardio-microcurrent device treatment for heart failure with reduced ejection fraction: Results from the C-MIC II open-label randomized controlled trialJesus E Rame, Jan D Schmitto, Dragana N Kosevic, et al.
Circulation. Heart Failure|November 18, 2016
One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection FractionDavid M Kaye, Gerd Hasenfuß, Petr Neuzil, et al.
Pageof 27

Showing results (231-240 of 263) with videos related to

Sort By:
Pageof 27
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|June 22, 2010
PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO studyYves-Laurent Bayard, Heyder Omran, Petr Neuzil, et al.
Heart Rhythm|February 8, 2026
Impact of linear ablation in persistent atrial fibrillation using a dual energy, wide-footprint catheter - Analysis from the SPHERE Per-AF Randomized TrialMoussa Mansour, Dinesh Sharma, Erich L Kiehl, et al.
Heart Rhythm O2|April 27, 2026
Same day discharge can be performed safely after atrial fibrillation catheter ablation using a wide-footprint lattice-tip dual-energy systemTyler L Taigen, Devi G Nair, Dinesh Sharma, et al.
Journal of the American College of Cardiology|November 8, 2021
4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial FibrillationPavel Osmancik, Dalibor Herman, Petr Neuzil, et al.
Journal of Cardiovascular Electrophysiology|August 2, 2023
Nonprocedural bleeding after left atrial appendage closure versus direct oral anticoagulants: A subanalysis of the randomized PRAGUE-17 trialMarian Branny, Pavel Osmancik, Petr Kala, et al.
Journal of the American College of Cardiology|June 27, 2020
Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial FibrillationPavel Osmancik, Dalibor Herman, Petr Neuzil, et al.
European Journal of Heart Failure|March 17, 2026
Long-term Safety and Performance of an Implantable IVC Sensor for Congestion-Guided Management in Heart Failure: 12-Month Results from the FUTURE-HF Trial PortfolioKevin Damman, Nir Uriel, Mandeep R Mehra, et al.
The New England Journal of Medicine|November 10, 2015
A Leadless Intracardiac Transcatheter Pacing SystemDwight Reynolds, Gabor Z Duray, Razali Omar, et al.
European Journal of Heart Failure|July 15, 2025
Cardio-microcurrent device treatment for heart failure with reduced ejection fraction: Results from the C-MIC II open-label randomized controlled trialJesus E Rame, Jan D Schmitto, Dragana N Kosevic, et al.
Circulation. Heart Failure|November 18, 2016
One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection FractionDavid M Kaye, Gerd Hasenfuß, Petr Neuzil, et al.
Pageof 27